Skip to main content
. 2016 May 13;7(4):428–436. doi: 10.1111/1759-7714.12350

Figure 4.

Figure 4

Blinded and randomized detection of epidermal growth factor receptor (EGFR) mutations by electric field‐induced release and measurement assay in plasma collected after surgery from patients with non‐small cell lung cancer: (a) the probe for EGFR exon 19 deletion; (b) the probe for L858R; and (c) receiver operating characteristic curves for detecting EGFR exon 19 deletion (area under the curve [AUC = 1) and L858R mutations (AUC = 0.96), respectively.